Dr. Lena Krzyzak

Principal / Authorized Signatory

Dr. Lena Krzyzak

Principal / Authorized Signatory

Lena joined HTGF in 2016 and is a Principal / Authorized Signatory in the Life Science Team. She is currently responsible for several portfolio companies in the fields of medical technology, drug development, biotechnology and digital health as well as for sourcing and completion of new early-stage investments. Before, she worked as Postdoctoral Researcher at the University Hospital in Erlangen and obtained her PhD in Immunology within a DFG-funded Fast-track PhD program at the Friedrich-Alexander University Erlangen-Nürnberg. The thesis resulted in several publications in renowned journals. Lena received her Bachelor’s degree from the Georg-August University Göttingen with studies abroad in Umeå (Sweden) and Singapore.

Contact

Telefon:
+49 – (0)228 – 82300 – 145

Portfolio

Posts & mentions

Press
21. July 2020

Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates

Tubulis today announced the close of a €10.7 million Series A financing round to accelerate the development of a new class of highly stable and efficient antibody-drug conjugates (ADCs) and to support the further growth of the company. The financing round was co-led by BioMedPartners and High-Tech Gründerfonds (HTGF) with support from Seventure Partners, coparion, Bayern Kapital, and OCCIDENT alongside significant contributions by high net worth individuals and the founders. Tubulis was s